Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management

IgA nephropathy (IgAN) is the commonest biopsy-reported primary glomerulonephritis worldwide. It has an incidence which peaks among young adults, and 30 to 40% of patients’ progress to end stage kidney disease within twenty years of diagnosis. Ten-year kidney survival rates have been reported to be...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Haresh Selvaskandan, Sufang Shi, Sara Twaij, Chee Kay Cheung, Jonathan Barratt
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Subjects:	IgA nephropathy biomarkers treatment Berger’s disease management biomarkers in IgA nephropathy
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.572754/full